| human | Q5 |
| P735 | given name | Dorothy | Q2647244 |
| Dorothy | Q2647244 | ||
| P106 | occupation | researcher | Q1650915 |
| Q37693261 | 'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'. |
| Q36852542 | A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion |
| Q88814890 | A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion |
| Q77595358 | Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain |
| Q34997854 | Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy |
| Q79249946 | Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy |
| Q35769605 | Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance |
| Q37357666 | Adenylyl cyclase type 5 disruption prolongs longevity and protects the heart against stress. |
| Q37054928 | Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. |
| Q37430967 | Adenylyl cyclase type 5 protein expression during cardiac development and stress. |
| Q44438499 | Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates |
| Q79743503 | Altered autonomic control in conscious transgenic rabbits with overexpressed cardiac Gsalpha |
| Q77548706 | Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction |
| Q28566847 | An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p |
| Q52681248 | Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck). |
| Q35825883 | Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function |
| Q37298308 | Apoptosis predominates in nonmyocytes in heart failure |
| Q30471712 | Arterial Pressure Monitoring in Mice |
| Q34014717 | Autophagy in chronically ischemic myocardium. |
| Q83738256 | Autophagy in ischemic preconditioning and hibernating myocardium |
| Q33996612 | Autophagy: a novel protective mechanism in chronic ischemia. |
| Q35749597 | Best anesthetics for assessing left ventricular systolic function by echocardiography in mice |
| Q34995850 | Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis |
| Q35190787 | Caloric restriction reduces growth of mammary tumors and metastases |
| Q37300597 | Calorie restriction can reverse, as well as prevent, aging cardiomyopathy. |
| Q36844536 | Cardiac dysfunction in aging conscious rats: altered cardiac cytoskeletal proteins as a potential mechanism |
| Q30476292 | Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. |
| Q35900954 | Cardiomyocyte overexpression of the α1A-adrenergic receptor in the rat phenocopies second but not first window preconditioning. |
| Q33338375 | Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure |
| Q44659637 | Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy |
| Q36822196 | Common mechanisms for calorie restriction and adenylyl cyclase type 5 knockout models of longevity |
| Q37406242 | Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. |
| Q50193427 | Disruption of adenylyl cyclase type 5 mimics exercise training |
| Q46983568 | Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress |
| Q35815013 | Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. |
| Q34519386 | Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade |
| Q42535729 | Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes |
| Q37899759 | Echocardiography in Mice |
| Q34150511 | Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload |
| Q28578076 | Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes |
| Q52588850 | Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14. |
| Q36730640 | Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates |
| Q44513062 | Gender differences on the effects of aging on cardiac and peripheral adrenergic stimulation in old conscious monkeys |
| Q37430992 | Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload |
| Q44567699 | Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart |
| Q100941208 | Healthful Aging Mediated by Inhibition of Oxidative Stress |
| Q42788037 | Heart Rate and Electrocardiography Monitoring in Mice |
| Q91707280 | Hsp22 overexpression induces myocardial hypertrophy, senescence and reduced life span through enhanced oxidative stress |
| Q37240644 | Increased apoptosis and myocyte enlargement with decreased cardiac mass; distinctive features of the aging male, but not female, monkey heart |
| Q37342081 | Increased vascular smooth muscle cell stiffness: a novel mechanism for aortic stiffness in hypertension |
| Q35511952 | Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection |
| Q41954132 | Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor |
| Q44764126 | Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals |
| Q73195643 | Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus |
| Q44586508 | Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. |
| Q51744228 | Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates |
| Q96341265 | Mechanisms of Increased Vascular Stiffness Down the Aortic Tree in Aging, Pre-Menopausal Female Monkeys |
| Q90271637 | Mechanisms of sex differences in exercise capacity |
| Q37693281 | Metabolomic analysis of two different models of delayed preconditioning |
| Q24653709 | MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths |
| Q42214151 | Models of longevity (Calorie Restriction and AC5 KO): Result of three bad hypotheses |
| Q36848480 | Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. |
| Q34150639 | Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. |
| Q35170119 | Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis |
| Q38797807 | Myocardial apoptosis in heart disease: does the emperor have clothes? |
| Q35180152 | Myocardial ischemic protection in natural mammalian hibernation |
| Q79073845 | Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy |
| Q30534315 | Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload |
| Q79306354 | Obligatory role of cardiac nerves and alpha1-adrenergic receptors for the second window of ischemic preconditioning in conscious pigs |
| Q83296544 | Overexpressed cardiac Gsalpha in rabbits |
| Q36201986 | Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling |
| Q35035194 | Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart |
| Q46624709 | Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy. |
| Q44443253 | Persistent stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. |
| Q34784422 | Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase |
| Q51789554 | Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition |
| Q36042480 | Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase |
| Q44970372 | Program of cell survival underlying human and experimental hibernating myocardium |
| Q33724552 | Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha |
| Q44761708 | Propranolol prevents enhanced stress signaling in Gs alpha cardiomyopathy: potential mechanism for beta-blockade in heart failure. |
| Q36176629 | Proteomic Mechanisms of Cardioprotection during Mammalian Hibernation in Woodchucks, Marmota Monax |
| Q90626174 | Rats are Protected from the Stress of Chronic Pressure Overload as Compared with Mice |
| Q37081518 | Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning |
| Q92329437 | Reply to "Letter to the Editor: Mechanisms of sex differences in exercise capacity" |
| Q42428411 | Reply to "Letter to the editor: When what you see may not be what you get: prudent considerations of anesthetics for murine echocardiography". |
| Q47615561 | Reply to: "Letter to the editor: Ketamine-only versus isoflurane effects on murine cardiac function: comparison at similar depths of anesthesia?". |
| Q51648442 | Response to Letter to the Editor on "Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?". |
| Q35538209 | Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia |
| Q104499166 | Secreted Frizzled Protein 3 Is A Novel Cardioprotective Mechanism Unique to the Clinically Relevant 4th Window of Ischemic Preconditioning |
| Q96766916 | Secreted frizzled-related protein 2, a novel mechanism to induce myocardial ischemic protection through angiogenesis |
| Q43106423 | Sex differences in myocardial infarction and rupture |
| Q80211278 | Sex-specific regulation of gene expression in the aging monkey aorta |
| Q42143605 | Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging |
| Q28730183 | Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension |
| Q41986224 | Temporal analysis of vascular smooth muscle cell elasticity and adhesion reveals oscillation waveforms that differ with aging |
| Q34793636 | The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. |
| Q42444813 | Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation |
| Q80700459 | Type 5 adenylyl cyclase disruption increases longevity and protects against stress |
| Q28397733 | Type 5 adenylyl cyclase disruption leads to enhanced exercise performance |
| Q37693302 | Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway |
Search more.